Alexandria Real Estate Equities, Inc. Overview
Pro stress-test →Alexandria Real Estate Equities is the preeminent owner, operator, and developer of life science real estate. The S&P 500-listed REIT pioneered the life science real estate niche in 1994 and operates 35.9 million rentable square feet across AAA innovation clusters in major biotech hubs including Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
Strategic Profile
Pro stress-test →Alexandria's competitive advantage stems from its portfolio of Class A/A+ properties designed as collaborative "Megacampus" ecosystems that enhance tenant ability to recruit talent and drive innovation. The company combines real estate operations with a venture capital platform to support transformative life science companies, creating a unique dual revenue model and deepening tenant relationships.
Competitive Landscape
Pro stress-test →Alexandria dominates the life science REIT sector with no direct competitors of equivalent scale and specialization. However, it competes indirectly with other commercial REITs (SL Green, BXP, Essex Property) and traditional office landlords for tenant attention. Its competitive advantage lies in focused expertise in life science real estate and established presence in premium innovation clusters, though sector-wide lab space oversupply and biotech funding constraints challenge all players.
Industry Context
Alexandria Real Estate Equities, Inc. operates in Real Estate Investment Trust (REIT) - Life Science Real Estate.
Key facts
Founded: 1994 · Headquarters: Pasadena, US · Revenue: $3.12B · Market cap: $20.75B